These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 37239813)

  • 21. Re-Imagining Drug Discovery using Mass Spectrometry.
    Cooks RG; Feng Y; Huang KH; Morato NM; Qiu L
    Isr J Chem; 2023 Aug; 63(7-8):. PubMed ID: 37829547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observation of electrochemically generated nitrenium ions by desorption electrospray ionization mass spectrometry.
    Brown TA; Hosseini-Nassab N; Chen H; Zare RN
    Chem Sci; 2016 Jan; 7(1):329-332. PubMed ID: 28791096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desorption electrospray ionization mass spectrometry imaging in discovery and development of novel therapies.
    Soudah T; Zoabi A; Margulis K
    Mass Spectrom Rev; 2023 Mar; 42(2):751-778. PubMed ID: 34642958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface analysis of lipids by mass spectrometry: more than just imaging.
    Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
    Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections.
    Fresnais M; Liang S; Seven D; Prodanovic N; Sundheimer J; Haefeli WE; Burhenne J; Longuespée R
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical imaging with desorption electrospray ionization mass spectrometry.
    Kertesz V; Van Berkel GJ
    Methods Mol Biol; 2010; 656():231-41. PubMed ID: 20680594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian ovarian lipid distributions by desorption electrospray ionization-mass spectrometry (DESI-MS) imaging.
    Cordeiro FB; Jarmusch AK; León M; Ferreira CR; Pirro V; Eberlin LS; Hallett J; Miglino MA; Cooks RG
    Anal Bioanal Chem; 2020 Feb; 412(6):1251-1262. PubMed ID: 31953714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid drug detection in whole blood droplets using a desorption electrospray ionization static profiling approach - a proof-of-concept.
    Fresnais M; Haefeli WE; Burhenne J; Longuespée R
    Rapid Commun Mass Spectrom; 2020 Mar; 34(6):e8614. PubMed ID: 31657865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Assessment of the Utility of Tissue Smears in Rapid Cancer Profiling with Desorption Electrospray Ionization Mass Spectrometry (DESI-MS).
    Woolman M; Tata A; Bluemke E; Dara D; Ginsberg HJ; Zarrine-Afsar A
    J Am Soc Mass Spectrom; 2017 Jan; 28(1):145-153. PubMed ID: 27730523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Quantitative Platforms for Single Target Mass Spectrometry Imaging.
    Bowman AP; Sawicki J; Talaty NN; Buck WR; Yang J; Wagner DS
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.
    Sigaud R; Rösch L; Gatzweiler C; Benzel J; von Soosten L; Peterziel H; Selt F; Najafi S; Ayhan S; Gerloff XF; Hofmann N; Büdenbender I; Schmitt L; Foerster KI; Burhenne J; Haefeli WE; Korshunov A; Sahm F; van Tilburg CM; Jones DTW; Pfister SM; Knoerzer D; Kreider BL; Sauter M; Pajtler KW; Zuckermann M; Oehme I; Witt O; Milde T
    Neuro Oncol; 2023 Mar; 25(3):566-579. PubMed ID: 35882450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue Sections.
    Fresnais M; Liang S; Breitkopf M; Lindner JR; Claude E; Pringle S; Levkin PA; Demir K; Benzel J; Sundheimer J; Statz B; Pajtler KW; Pfister SM; Haefeli WE; Burhenne J; Longuespée R
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices-A Practical Example.
    Fresnais M; Karabulut S; Abou Zeed Y; Ungermann J; Benzel J; Pajtler KW; Pfister SM; Haefeli WE; Burhenne J; Longuespée R
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desorption/Ionization-MS Methods for Drug Quantification in Biological Matrices and Their Validation Following Regulatory Guidance.
    Fresnais M; Burhenne J; Haefeli WE; Longuespée R
    Anal Chem; 2021 May; 93(19):7152-7163. PubMed ID: 33914512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-validated Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Quantitation Protocol for a Pharmaceutical Drug and Its Drug-Target Effects in the Brain Using Time-of-Flight and Fourier Transform Ion Cyclotron Resonance Analyzers.
    Källback P; Vallianatou T; Nilsson A; Shariatgorji R; Schintu N; Pereira M; Barré F; Wadensten H; Svenningsson P; Andrén PE
    Anal Chem; 2020 Nov; 92(21):14676-14684. PubMed ID: 33086792
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.